Medicine
Dipyridamole 50 mg/10 mL injection
Dipyridamole 50 mg/10 mL injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Avoid freezing. Store at 25ºC (77ºF), excursions permitted between 15º to 30ºC…
Key facts
- Active ingredient (INN)
- Dipyridamole
- Brand
- Sold under the generic name
- Strength
- 50 mg/10 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 5 vials of 10 mL, 10 mL, 1 vial of 10 mL
- Manufacturers
- HealthFirstHenry ScheinHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Avoid freezing. Store at 25ºC (77ºF), excursions permitted between 15º to 30ºC (59º to 86ºF). Storage PROTECT FROM LIGHT: Keep covered in carton until time of use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC07 Dipyridamole
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 October 1996
- Identifiers
- RxCUI 309953DailyMed set ID 6093dcd9-82d2-414f-8507-eda22c14f626, 9bd34108-9d98-c4ca-e053-2995a90a2bc8, 1a2c0a9a-c637-4485-ad4b-0b6d0b05fa20NDC 0641-2569, 51662-1447, 0404-9852Application ANDA074521
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 vial in 1 carton / 10 mL in 1 vial | 0641-2569-44 | Hikma Pharmaceuticals | 18 October 1996 |
| 10 mL in 1 vial | 51662-1447-1 | HealthFirst | 10 January 2020 |
| 1 vial, single-dose in 1 bag / 10 mL in 1 vial, single-dose | 0404-9852-10 | Henry Schein | 10 January 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 December 1961 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Dipyridamole
Clinical summary
Dipyridamole is a platelet aggregation inhibitor indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately. MedsAcross supplies Dipyridamole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DipyridamoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dipyridamole prescribing information (Hikma Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Dipyridamole 50 mg/10 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.